The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Short Interest Update

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) saw a large increase in short interest during the month of November. As of November 15th, there was short interest totalling 41,000 shares, an increase of 290.5% from the October 31st total of 10,500 shares. Based on an average trading volume of 26,100 shares, the short-interest ratio is currently 1.6 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Stock Up 0.6 %

Shares of NASDAQ CGABL traded up $0.11 during midday trading on Thursday, reaching $19.25. 8,935 shares of the stock were exchanged, compared to its average volume of 22,087. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a twelve month low of $17.49 and a twelve month high of $20.85. The company has a 50 day simple moving average of $19.83 and a 200 day simple moving average of $19.04.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Saturday, November 15th. Stockholders of record on Saturday, November 1st will be paid a dividend of $0.2891 per share. This represents a $1.16 annualized dividend and a dividend yield of 6.01%. The ex-dividend date is Friday, October 31st.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Company Profile

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.